ADVERSE DRUG EVENT
Clinical trials for ADVERSE DRUG EVENT explained in plain language.
Never miss a new study
Get alerted when new ADVERSE DRUG EVENT trials appear
Sign up with your email to follow new studies for ADVERSE DRUG EVENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New sedative tested to help ICU patients breathe on their own sooner
Disease control Recruiting nowThis study compares two sedation drugs (remazolam besylate vs dexmedetomidine) for patients who need breathing machine support in the ICU after non-cardiac surgery. It aims to see if the new drug is at least as safe and effective at helping patients wake up and breathe on their o…
Matched conditions: ADVERSE DRUG EVENT
Phase: PHASE4 • Sponsor: Beijing Shijitan Hospital, Capital Medical University • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Heart surgery study seeks goldilocks dose for bleeding drug
Disease control Recruiting nowThis study aims to find the best dose of a common drug (tranexamic acid) used to control bleeding during heart surgery. Researchers will compare three different dosing plans in 150 patients to see which one works longest to prevent bleeding problems while minimizing side effects …
Matched conditions: ADVERSE DRUG EVENT
Phase: NA • Sponsor: University of Ioannina • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
Common sleep aid may shield kidneys from powerful antibiotics
Prevention Recruiting nowThis study is testing whether melatonin, a common over-the-counter supplement, can prevent kidney damage in hospitalized patients who need strong antibiotics. It will involve 300 adults who are prescribed a specific combination of antibiotics. Participants will receive either mel…
Matched conditions: ADVERSE DRUG EVENT
Phase: PHASE3 • Sponsor: Rutgers, The State University of New Jersey • Aim: Prevention
Last updated Mar 30, 2026 14:33 UTC
-
Scientists hunt genetic clues to make leukemia treatment safer for kids
Knowledge-focused Recruiting nowThis study aims to understand how a child's genes might influence their risk of severe side effects and how well they respond to standard leukemia treatment. Researchers will observe about 550 Indian children with acute lymphoblastic leukemia (ALL) to find genetic markers linked …
Matched conditions: ADVERSE DRUG EVENT
Sponsor: University of Geneva, Switzerland • Aim: Knowledge-focused
Last updated Mar 17, 2026 12:55 UTC